AI Engines For more Details: Perplexity Kagi Labs You
Bronchodilation: Khellin has been investigated for its bronchodilatory effects, which means it may help widen the airways in the lungs. This property has led to its exploration in the treatment of respiratory conditions such as asthma.
Antispasmodic: Khellin has been reported to possess antispasmodic properties, which could make it useful in alleviating muscle spasms or cramps.
Vasodilation: Some studies suggest that khellin may have vasodilatory effects, meaning it can widen blood vessels. This property could potentially be beneficial in conditions where improved blood flow is desired, such as certain cardiovascular conditions.
Phototherapy: Khellin has been studied for its photosensitizing properties, particularly in combination with ultraviolet A (UVA) light. This combination, known as PUVA therapy (psoralen combined with ultraviolet A), has been used in the treatment of certain skin conditions like psoriasis and vitiligo.
Antimicrobial: There is some evidence to suggest that khellin may possess antimicrobial properties, although further research is needed to fully understand its potential in this area.
Rank | Probiotic | Impact |
---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
ADHD | 0.3 | 0 | 0 |
Age-Related Macular Degeneration and Glaucoma | 0 | 0 | |
Allergies | 0.1 | 0.4 | -3 |
Allergy to milk products | 0.2 | 0.2 | |
Alzheimer's disease | 0.2 | 0.5 | -1.5 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0 | 0.2 | 0 |
Ankylosing spondylitis | 0.2 | -0.2 | |
Anorexia Nervosa | 0.3 | -0.3 | |
Asthma | 0 | 0 | 0 |
Atherosclerosis | 0.2 | 0 | 0 |
Atrial fibrillation | 0.2 | 0.2 | |
Autism | 0.4 | 0.3 | 0.33 |
Bipolar Disorder | 0.2 | 0.3 | -0.5 |
Brain Trauma | 0 | 0 | |
Carcinoma | 0.2 | 0.2 | 0 |
Celiac Disease | 0.2 | -0.2 | |
Cerebral Palsy | 0.2 | -0.2 | |
Chronic Fatigue Syndrome | 0.4 | 0 | 0 |
Chronic Kidney Disease | 0 | 0.1 | 0 |
Chronic Lyme | 0 | 0 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0 | 0 | |
Coagulation / Micro clot triggering bacteria | 0.2 | -0.2 | |
Colorectal Cancer | 0.2 | 0 | 0 |
Constipation | 0 | 0 | |
Coronary artery disease | 0.2 | 0 | 0 |
COVID-19 | 0.2 | 0.8 | -3 |
Crohn's Disease | 0.3 | 0.3 | 0 |
cystic fibrosis | 0 | 0 | |
deep vein thrombosis | 0.2 | -0.2 | |
Depression | 0.4 | 0.4 | 0 |
Endometriosis | 0 | 0.2 | 0 |
Fibromyalgia | 0 | 0 | 0 |
Functional constipation / chronic idiopathic constipation | 0.2 | 0.1 | 1 |
gallstone disease (gsd) | 0.2 | 0 | 0 |
Generalized anxiety disorder | 0 | 0 | |
Gout | 0 | 0 | |
Graves' disease | 0 | 0 | |
Hashimoto's thyroiditis | 0.1 | 0.1 | |
Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.1 | 0.1 | 0 |
hypertension (High Blood Pressure | 0.2 | 0.1 | 1 |
Hypothyroidism | 0 | 0 | |
Inflammatory Bowel Disease | 0 | 0.8 | 0 |
Insomnia | 0 | 0 | |
Intelligence | 0 | 0 | |
Intracranial aneurysms | 0.2 | 0.2 | |
Irritable Bowel Syndrome | 0.2 | 0 | 0 |
Liver Cirrhosis | 0.2 | 0.2 | 0 |
Long COVID | 0.1 | 0.7 | -6 |
Low bone mineral density | 0 | 0 | |
Lung Cancer | 0.2 | -0.2 | |
ME/CFS with IBS | 0 | 0 | |
ME/CFS without IBS | 0.1 | 0.1 | |
Metabolic Syndrome | 0.3 | 0.3 | 0 |
Mood Disorders | 0.6 | 0.4 | 0.5 |
Multiple Sclerosis | 0.2 | 0.3 | -0.5 |
Multiple system atrophy (MSA) | 0.1 | 0.2 | -1 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.3 | -0.3 | |
Obesity | 0.4 | 0.2 | 1 |
obsessive-compulsive disorder | 0.5 | 0.1 | 4 |
Osteoarthritis | 0.2 | -0.2 | |
Osteoporosis | 0.2 | 0.2 | |
Parkinson's Disease | 0 | 0.3 | 0 |
Polycystic ovary syndrome | 0.2 | 0.5 | -1.5 |
Postural orthostatic tachycardia syndrome | 0 | 0 | |
Psoriasis | 0.2 | 0 | 0 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.3 | 0 | 0 |
Rosacea | 0.3 | 0 | 0 |
Schizophrenia | 0.2 | 0.2 | 0 |
scoliosis | 0 | 0.2 | 0 |
Sjögren syndrome | 0 | 0 | |
Sleep Apnea | 0.2 | 0 | 0 |
Stress / posttraumatic stress disorder | 0 | 0.1 | 0 |
Systemic Lupus Erythematosus | 0 | 0.2 | 0 |
Tic Disorder | 0.2 | 0.2 | |
Type 1 Diabetes | 0.2 | 0 | 0 |
Type 2 Diabetes | 0.3 | 0.2 | 0.5 |
Ulcerative colitis | 0 | 0 | |
Unhealthy Ageing | 0.1 | 0.1 | 0 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.